Home・Lista de Ações・Cytek Biosciences Inc

Cytek Biosciences Inc

Abrir

SetorSaúde

4.68 1.3

Comprar Vender

Visão Geral

Variação de preço das ações

24h

Atual

Mín

4.44

Máximo

4.73

Indicadores-chave
By Trading Economics
Rendimento	6.7M -12M
Vendas	4M 48M
EPS	-0.09
Margem de lucro	-25.256
Funcionários	682
EBITDA	5.9M -8.4M

Recomendações
By TipRanks
Recomendações	Comprar
Previsão para 12 meses	+31.29% upside

Dividendos
By Acuity
Próximos Ganhos	4 de nov. de 2026

Estatísticas de Mercado
By TradingEconomics
Capitalização de Mercado	21M 577M
Abertura anterior	3.38
Fecho anterior	4.68

Sentimento de Notícias

By Acuity

50%

145 / 340 Ranking em Healthcare

Cytek Biosciences Inc Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

27 de ago. de 2026, 20:07 UTC

Cytek Biosciences Inc shares are higher, reflecting a positive trend since Wednesday. A decline in jobless claims supports the favorable market backdrop.

25 de ago. de 2026, 19:26 UTC

Cytek Biosciences Inc is trading higher during Tuesday's session, reflecting a stable backdrop amid rising U.S. Treasury yields that support equity valuations.

24 de ago. de 2026, 20:01 UTC

Cytek Biosciences Inc. shares are trading lower amid a broader market decline and geopolitical concerns over U.S. sanctions on Iran affecting oil supply.

21 de ago. de 2026, 22:01 UTC

News

Cytek Biosciences shares are lower in after-market hours following a jury's $56 million damages award to Beckman Coulter for patent infringement.

19 de ago. de 2026, 19:26 UTC

Cytek Biosciences Inc shares are higher today, reaching an intraday high before retracing slightly. The stock remains above its 20-day moving average.

18 de ago. de 2026, 19:46 UTC

Cytek Biosciences Inc shares are lower today, reaching a session low earlier. Rising Treasury yields amid inflation concerns may be affecting investor sentiment.

14 de ago. de 2026, 20:02 UTC

Cytek Biosciences shares declined during Friday's session, following a broader market trend after U.S. retail sales unexpectedly fell in July.

13 de ago. de 2026, 19:51 UTC

Cytek Biosciences Inc shares are advancing, reflecting a cumulative gain over seven sessions. No specific company news was identified to explain the movement.

12 de ago. de 2026, 20:06 UTC

Cytek Biosciences Inc. shares are roughly flat during Wednesday's session. Broader market performance remains unchanged amid geopolitical tensions and U.S. Treasury yields.

11 de ago. de 2026, 23:06 UTC

Cytek Biosciences Inc. shares showed little change during after-market hours, trading within a narrow range without any specific news or developments.

10 de ago. de 2026, 19:51 UTC

Cytek Biosciences Inc shares are higher in Monday's session, continuing an upward trend since Friday. No specific news was identified to explain the movement.

7 de ago. de 2026, 19:36 UTC

Cytek Biosciences Inc is higher today, supported by broader market gains amid expectations of a Federal Reserve pause on interest rate hikes.

6 de ago. de 2026, 20:02 UTC

News

Cytek Biosciences raises 2026 revenue guidance to $207 million-$212 million, aligning with consensus. Shares are higher despite a mixed earnings report.

5 de ago. de 2026, 22:02 UTC

News

Cytek Biosciences shares are lower in after-market hours following a second-quarter earnings miss and revenue that fell short of expectations.

4 de ago. de 2026, 20:06 UTC

Cytek Biosciences Inc. shares are lower today, reflecting broader market trends after a notable early peak. Overall market performance has declined since Monday.

3 de ago. de 2026, 19:56 UTC

Cytek Biosciences Inc. shares are higher today, reflecting broader market trends as major indices gain amid easing geopolitical tensions. No specific news was identified.

31 de jul. de 2026, 19:26 UTC

Correlated Moves

Cytek Biosciences Inc shares are lower as first-quarter results show a significant decline, reflecting broader sector pressures amid rising bond yields.

30 de jul. de 2026, 19:18 UTC

Cytek Biosciences Inc. shares are lower today, reflecting ongoing weakness and trading significantly below the 20-day moving average amid broader market volatility.

27 de jul. de 2026, 19:56 UTC

Cytek Biosciences Inc is trading lower today, retracing from an early peak. The asset remains near the lower end of its one-month trading range.

24 de jul. de 2026, 17:16 UTC

Cytek Biosciences Inc. shares are lower today, declining after an early peak. The asset remains below its 20-day moving average amid broader market volatility.

23 de jul. de 2026, 19:46 UTC

Cytek Biosciences Inc. shares are trading roughly flat, reflecting limited movement since Wednesday. Earlier, shares peaked before retracing to current levels.

21 de jul. de 2026, 19:06 UTC

Cytek Biosciences Inc shares are lower today, continuing a three-session decline amid broader market conditions. No specific news was identified to explain the movement.

20 de jul. de 2026, 19:06 UTC

Cytek Biosciences Inc. shares are lower today, reflecting routine fluctuations near the upper end of their one-month trading range amid a broader market decline.

Comparação entre Pares

Variação de preço

Cytek Biosciences Inc Previsão

Preço-alvo

By TipRanks

31.29% parte superior

Previsão para 12 meses

Média 6 USD 31.29%

Máximo 7.5 USD

Mínimo 5 USD

Com base em 3 analistas de Wall Street que oferecem metas de preço de 12 meses para Cytek Biosciences Inc - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Comprar

3 ratings

Comprar

Manter

Vender

Com base em 3 analistas que deram avaliações de ações para Cytek Biosciences Inc - Dist nos últimos 3 meses.

Sentimento

By Acuity

145 / 340 Ranking em Saúde

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

Sobre Cytek Biosciences Inc

Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells; and aurora cell sorter system that leverages full spectrum profiling technology to further broaden potential applications across cell analysis; aurora CS systems; amnis imagestream imaging flow cytometers; guava muse cell analyzers; guava easycyte flow cytometers; and orion reagent cocktail preparation systems. The company also provides reagents and kits, including cFluor reagents that are fluorochrome conjugated antibodies used to identify cells of interest for analysis on its instruments, as well as 25-color immunoprofiling assay that provides turnkey solutions for identifying major human immune subpopulations for TBNK cells, monocytes, dendritic cells, and basophils. In addition, it offers automated micro-sampling system and automated sample loader system, an automated loaders to integrate seamlessly into the aurora and northern lights systems; SpectroFlo software that provides intuitive workflow from quality control to data analysis for aurora and northern lights systems; and customer support tools. The company serves pharmaceutical and biopharma companies, academic research centers, and clinical research organizations. It distributes its products through direct sales force and support organizations in North America, Europe, China, and the Asia-Pacific regions; and through distributors or sales agents in European, Latin American, and the Middle Eastern countries. The company was formerly known as Cytoville, Inc. and changed its name to Cytek Biosciences, Inc. in August 2015. Cytek Biosciences, Inc. was founded in 1992 and is headquartered in Fremont, California.